Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants

Xenotransplantation

Volumn 11, Issue 2, 2004, Pages 123-132

  Chen, Gang ^a   Sun, Qian Yun ^b   Wang, Xi Mo ^a   Shen, Shi Qian ^a   Guo, Hui ^a   Wang, Hong ^a   Wu, Ying ^a   Wang, Wan Yu ^b   Xiong, Yu Liang ^b   Chen, Shi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Acute vascular rejection; Heart transplantation; Pig to rhesus monkey model; Xenotransplantaion; Yunnan cobra venom factor

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; UNCLASSIFIED DRUG; YUNNAN COBRA VENOM FACTOR;

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEPOSITION; COMPLEMENT HEMOLYSIS TEST; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL TRANSPLANTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; HYPERACUTE GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; MULTIPLE DRUG DOSE; NAJA KAOUTHIA; NEWBORN; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RHESUS MONKEY; SNAKE; SWINE; SWINE TO RHESUS MONKEY MODEL; TRANSGENIC ANIMAL; XENOTRANSPLANTATION;

ANIMALS; COMPLEMENT C3; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT SYSTEM PROTEINS; ELECTROCARDIOGRAPHY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; MACACA MULATTA; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 10744224176     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00048.x     Document Type: Article

References (42)

1. DALMASSO AP, VERCELLOTTI GM, PLATT JL, BACH FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52: 530.
2. PLATT JL. Understanding the mechanism of hyperacute rejection. Graft 2001, 4: 8.
3. SOIN B, VIAL CM, MASROOR S et al. Peri-operative TP10 (sCRI) improves early graft function and in combination with RAD and neural extends survival after prolonged cold ischaemia in hDAF-transgenic pig to primate renal xenotransplantation. Transplantation 2000; 69: S252.
4. VANGEROW B, HECKER JM, LORENZ R et al. Cl-inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation 2001; 8: 266.
5. CHEN RH, NAFICY S, LOGAN JS et al. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6: 194.
6. VIAL CM, OSTLIE DJ, BHATTI FN et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19: 224.
7. BHATTI FNK, SCHMOECKEL M, ZAIDI A et al. Three-month survival of hDAF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 31: 958.
8. ZAIDI A, SCHMOECKEL M, BHATTI F et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
9. WATERWORTH PD, DUNNING J, TOLAN M et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17: 1201.
10. LOSS M, VANGEROW B, SCHMIDTKO J et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7: 186.
11. KOBAYASHI T, TANIGUCHI S, NEETHLING FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
12. DAVIS EA, PRUITT SK, GREENE PS et al. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 1996; 62: 1018.
13. SALERNO CT, KULICK DM, YEH CG et al. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation. Xenotransplantation 2002; 9: 125.
14. SUN QY, Lu QM, WANG WY, XIONG YL. A highly active anticomplement factor from the venom of Naja kaouthia. Acta Biochimica et Biophysica Sinica 2001; 33: 483.
15. BALLOW M, COCHRANE CG. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol 1969; 103: 944.
16. PEVVS MB, TOMPKINS C, SMITH AD. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A. J Immunol Meth 1979; 30: 105.
17. TAKAHASHI H, HAYASHI K. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom. Biochimica et Biophysica Acta 1982; 701: 102.
18. SHU YY, CHENG C, ZHUANG MX, TANG SX. Purification and characterization of cobra venom factor (CVF) from Chinese cobra (Naja naja atra). Acta Biochimica et Biophysica Sinica 1991; 23: 32.
19. LAEMMLI UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680.
20. KAWAUCHI S, IWANAGA S, SAMEJIMA Y, SUZUKI T. Isolation and characterization of two phospholipase A's from the venom of Agkistrodon halys blomhoffii. Biochimica et Biophysica Acta 1971; 236: 142.
21. ADAMS DH, CHEN RH, ALEXANDER KADNER et al. Technique for heterotopic pig heart xenotransplantation in primates. Ann Thorac Surg 1999; 68: 265.
22. MAYER MM. Complement and complement fixation. In: KABAT EA, MAYER MM, eds. Experimental Immunochemistry, 2nd ed. Springfield, IL: Charles C Thomas, 1961: 133.
23. MANCINI G, CARBONARA AO, HEREMANS JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 365.
24. PLATT JL, TURMAN MA, NOREEN H, FISCHEL RJ, BOLMAN BM III, BACH FH. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990; 49: 1000.
25. GIANELLO P. Preventing hyperacute rejection. Graft 2001; 4: 18.
26. WATTS A, FOLEY A, AWWAD M et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 320 aphereses in baboons. Xenotransplantation 2000; 7: 181.
27. KOBAYASHI T, YOKOYAMA I, MOROZUMI K et al. Comparative study of the efficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis. Xenotransplantation 2000; 7: 101.
28. GHANEKAR A, LAJOIE G, LUO Y et al. Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serum. Transplantation 2002; 74: 28.
29. MACCHIARINI P, ORIOL R, AZIMZADEH A et al. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion. J Thorac Cardiovasc Surg 1998; 116: 831.
30. PHELPS CJ, KOIKE C, VAUGHT TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
31. FRYER JP, LEVENTHAL JR, PAO W et al. Synthetic peptides which inhibit the interaction between Clq and immunoglobulin and prolong xenograft survival. Transplantation 2000; 70: 828.
32. URATA K, BRAULT A, ROCHELEAU B, HUET PM. Role of Kupffer cells in the survival after rat liver transplantation with long portal vein clamping times. Transpl Int 2000; 13: 420.
33. BLUMBERG RS, SAUBERMANN LJ, STROBER W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999; 11: 648.
34. ANRATHER J, CSIZMADIA V, BROSTJAN C, SOARES MP, BACH FH, WINKLER H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J Clin Invest 1997; 99: 763.
35. EGGERTSEN G, LIND P, SJÖQUIST J. Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja n. siamensis). Mol Immunol 1981; 18: 125.
36. VOGEL C-W, MÜLLER-EBERHARD HJ. Cobra venom factor: improved method for purification and biochemical characterization. J Immunol Meth 1984; 73: 203.
37. CANDINAS D, LESNIKOSKI BA, ROBSON SC et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996; 62: 336.
38. HAYASHI S, ITO M, YOKOYAMA I, TAKAGI H. Evidence that combination therapy using cobra venom factor, splenectomy, and deoxyspergualin is effective in guinea pig to rat cardiac xenotransplantation. Transplantation 1994; 57: 777.
39. LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
40. TANIGUCHI S, KOBAYASHI T, NEETHLING FA et al. Cobra venom factor stimulates anti-α Galactose antibody production in baboons. Transplantation 1996; 62: 678.
41. ROSE AG, COOPER DKC. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000; 7: 31.
42. Roos A, ESSERS M, VAN GIJLSWIJK-JANSSEN D et al. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity. Xenotransplantation 2001; 8: 3.